US2004028751A1PendingUtilityA1

Compositions for preventing or ameliorating multiple risk factor syndromes

42
Priority: Dec 12, 2000Filed: Dec 12, 2001Published: Feb 12, 2004
Est. expiryDec 12, 2020(expired)· nominal 20-yr term from priority
Inventors:Tatsumasa MaeMisuzu TsukagawaHideyuki KishidaMitsuaki KitanoMikio KitaharaKaku Nakagawa
A61P 3/10A61P 43/00A61P 3/06A61P 3/04A61P 9/12A61K 8/9794A61K 8/9789A23L 33/175A61K 36/48A23L 33/10A61K 36/61A23L 33/15A61K 36/9066A23K 50/40A21D 2/36A23L 33/16A61Q 19/06A23L 33/105A23K 20/10A61K 36/54A23L 27/60A61K 36/236
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention aims at a composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension, which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.

Claims

exact text as granted — not AI-modified
1 . A composition for preventing or ameliorating multiple risk factor syndrome 
 which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.    
     
     
         2 . The composition according to  claim 1 , 
 which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a clove extract, and a cinnamon extract.    
     
     
         3 . The composition according to  claim 1 , 
 which comprises a licorice hydrophobic extract.    
     
     
         4 . The composition according to  claim 1 , 
 which comprises a turmeric extract.    
     
     
         5 . The composition according to  claim 1 , 
 which comprises a clove extract.    
     
     
         6 . The composition according to  claim 1 , 
 which comprises a cinnamon extract.    
     
     
         7 . The composition according to  claim 1 , 
 which is for food/beverage use.    
     
     
         8 . The composition according to  claim 1 , 
 which is for medical use.    
     
     
         9 . The composition according to  claim 1 , 
 which is for human use.    
     
     
         10 . The composition according to  claim 1 , 
 which is for domestic or pet animal use.    
     
     
         11 . The composition according to  claim 1 , 
 which is for cosmetic or quasi-drug use.    
     
     
         12 . The composition according to  claim 1 , 
 wherein the multiple risk factor syndrome is at least one member selected from the group consisting of visceral fat-type obesity, diabetes mellitus, hyperlipemia, and hypertension.    
     
     
         13 . The composition according to  claim 1 , 
 wherein the multiple risk factor syndrome is visceral fat-type obesity.    
     
     
         14 . The composition according to  claim 1 , 
 wherein the multiple risk factor syndrome is diabetes mellitus.    
     
     
         15 . The composition according to  claim 1 , 
 wherein the multiple risk factor syndrome is hyperlipemia.    
     
     
         16 . The composition according to  claim 1 , 
 wherein the multiple risk factor syndrome is hypertension.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.